Clinical Trials
19 trialsNatural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
Center for International Blood and Marrow Transplant Research
Multicenter Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab, Bendamustine, Gemcitabine, Vinorelbine (Nivo-BeGEV) in Patients With Relapsed/Refractory Hodgkin Lymphoma
National Research Center for Hematology, Russia
Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study
Bioaraba Health Research Institute
VALERIA
Nordic Lymphoma Group
H10
European Organisation for Research and Treatment of Cancer - EORTC
R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS)
National Research Center for Hematology, Russia
De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL)
National Research Center for Hematology, Russia
Multicenter Clinical Trial for Adult Ph-negative ALL. Non-intensive But Non-iterruptive Treatment
National Research Center for Hematology, Russia
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
European Organisation for Research and Treatment of Cancer - EORTC
Tcell-Brazil
Grupo de Estudos Multicentricos em Onco-Hematologia
R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis
National Research Center for Hematology, Russia
BRiF
National Research Center for Hematology, Russia
Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children
The Korean Society of Pediatric Hematology Oncology
Q-lite
Czech CLL Study Group
Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)
The Korean Society of Pediatric Hematology Oncology
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia Research Consortium
CRC005
Chronic Lymphocytic Leukemia Research Consortium
A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL
Cooperative Study Group A for Hematology
Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma
Cooperative Study Group A for Hematology